Severe mpox in an immunocompromised patient, South Africa 2024

Authors

  • E Vardas Lancet Laboratories, Johannesburg, and Division of Medical Virology, Department of Pathology, University of Stellenbosch, Cape Town, South Africa https://orcid.org/0000-0002-7804-878X
  • M Naidoo Lancet Laboratories, Johannesburg, and Division of Medical Virology, Department of Pathology, University of Stellenbosch, Cape Town, South Africa https://orcid.org/0000-0001-7880-8868
  • N A I Chopdat Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, and Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • J Weyer Department of Virology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, and Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, South Africa
  • A I Ranchod Department of Radiology, School of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, and National Radiology Services Inc., Johannesburg, South Africa
  • L Moosa Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, and Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • A J Glass Lancet Laboratories, Department of Molecular Pathology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • L H Blumberg Department of Medical Microbiology, Stellenbosch University, Cape Town, South Africa, and Faculty of Veterinary Science, University of Pretoria, South Africa, and Right to Care, National Institute of Communicable Diseases, Johannesburg, South Africa
  • J Elskie Lenmed Ahmed Kathrada Hospital, Johannesbug, South Africa
  • W Garyson Division of Anatomical Pathology, University of the Witwatersrand, School of Pathology, Faculty of Health Sciences, Johannesburg, South Africa, and Ampath Laboratories, Johannesburg, South Africa
  • T Pitjadi Division of Anatomical Pathology, University of the Witwatersrand, School of Pathology, Faculty of Health Sciences, Johannesburg, South Africa, and Ampath Laboratories, Johannesburg, South Africa
  • Z Kalla Charlotte Maxeke Hospital, Johannesburg, South Africa

DOI:

https://doi.org/10.7196/SAMJ.2024.v114i10.2407

Keywords:

Severe mpox, immunosuppressed, HIV, new outbreak

Abstract

-

Author Biographies

  • E Vardas, Lancet Laboratories, Johannesburg, and Division of Medical Virology, Department of Pathology, University of Stellenbosch, Cape Town, South Africa

    Department of Virology and Immunology, Pathologist in Charge, Clinical Virologist,

  • M Naidoo, Lancet Laboratories, Johannesburg, and Division of Medical Virology, Department of Pathology, University of Stellenbosch, Cape Town, South Africa

    Department of Virology and Immunology, Pathologist, Clinical Virologist 

  • N A I Chopdat, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, and Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Lenmed Ahmed Kathrada Private Hospital, Johannesburg, South Africa. Physician

  • J Weyer, Department of Virology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, and Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, South Africa

    Centre for Emerging and Zoonotic Diseases at the National Insitute of Communicable Diseases, Centre Head and Principal Medical Scientist

  • A I Ranchod, Department of Radiology, School of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, and National Radiology Services Inc., Johannesburg, South Africa

    Honorary lecturer Department of Radiology, School of Medicine, Faculty of Health Sciences, University of the Witwatersrand and Director, founding and managing partner of National Radiology Services Inc

  • L Moosa, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, and Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Consultant Dermatologist. Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. 

    Charlotte Maxeke Johannesburg Academic Hospital South Africa

  • A J Glass, Lancet Laboratories, Department of Molecular Pathology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Lancet Laboratories, Clinical Virologist, Head of Molecular Pathology. Department of Molecular Pathology, School of Pathology, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa

  • L H Blumberg , Department of Medical Microbiology, Stellenbosch University, Cape Town, South Africa, and Faculty of Veterinary Science, University of Pretoria, South Africa, and Right to Care, National Institute of Communicable Diseases, Johannesburg, South Africa

    Clinical Microbiologist, Consultant Infectious Diseases, Right to Care, Honorary Consultant National Institute of Infectious Diseases, Honorary Lecturer University of Stellenbosch and University of Pretoria 

  • J Elskie, Lenmed Ahmed Kathrada Hospital, Johannesbug, South Africa

    Clinical Associate at the Centre for Digestive Diseases, Lenmed Ahmed Kathrada Hospital 

  • W Garyson , Division of Anatomical Pathology, University of the Witwatersrand, School of Pathology, Faculty of Health Sciences, Johannesburg, South Africa, and Ampath Laboratories, Johannesburg, South Africa

    Honorary Professor Divison Anatomical Pathology, University of the Witwatersrand, Professor Histopathology, Ampath laboratories

  • T Pitjadi , Division of Anatomical Pathology, University of the Witwatersrand, School of Pathology, Faculty of Health Sciences, Johannesburg, South Africa, and Ampath Laboratories, Johannesburg, South Africa

    Histopathologist Ampath Laboratories, Honorary lecturer Division of Anatomical Pathology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  • Z Kalla, Charlotte Maxeke Hospital, Johannesburg, South Africa

    Community Service Medical Officer, Charlotte Maxeke Hospital, Johannesburg, South Africa

References

1. De Clercq E, Jiang Y, Li G. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox and orf. Travel Med Infect Dis 2023;52:102528. https://doi.org/10.1016/j. tmaid.2022.102528

2. Alakunle E, Kolawole D, Diaz-Canova D, et al. A comprehensive review of monkeypox virus and mpox characteristics. Front Cellular Infect Microbiol 2024:14:1-20. https://doi.org/10.3389/fcimb.2024.1360586 3. Kibungu EM, Vakaniaki EH, Kinganda-Lusamaki E, et al. Clade I-associated mpox cases associated with sexual contact, the Democratic Republic of Congo. Emerg Infect Dis 2024;30(1):172-176. https://

doi.org/10.3201/eid3001.231164

4. Lu J, Xing H, Wang C, et al. Mpox (formerly monkeypox): Pathogenesis, prevention and treatment. Nature 2023:8:458. http://doi.org/10.1038/s41392-023-01675-2

5. Gupta AK, Talukder M, Rosen T, Piguet V. Differential diagnosis, prevention and treatment of mpox (Monkeypox): A review for dermatologists. Am J Clin Derm 2023:24(4):541-556. https://doi. org/10.1007/s40257-023-0078-4

6. Thornhill JP, Barkati S, Walmsey S, et al. Monkeypox virus infection in humans across 16 countries – April - June 2022. N Engl J Med 2022:387(25):e69. http://doi.org/10.1056/NEJMc2213969

7. Fink DL, Callaby H, Luintel A, et al. Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: A retrospective cohort study. Lancet Infect Dis 2023;23(5):589-597.http://doi.org/10.1016/S1473-3099(22)00806-4

8. South African Government. Minister Joe Phaahla on outbreak of Mpox disease in South Africa and efforts to curb the spread. 12 June 2024. https://www.gov.za/news/media-statements/minister-joe- phaahla-outbreak-mpox-disease-south-africa (accessed 12 June 2024).

9. Zeng Y, Liu X, Li Y, et al.The assessment on cross immunity with smallpox virus and antiviral drug sensitivity of the isolated mpox virus strain WIBP-MPXV-001 in China. Emerg Microbes Infect 2023;12(1):2208682. http://doi.org/10.1080/22221751.2023.2208682

10. Mitja O, Alemany A, Marks M, et al. Mpox in people with advanced HIV infection: A global case series. Lancet 2023;401(10380):939-949. http://doi.org/10.1016/S0140-6736(23)00273-8

11. Moltrasio C, Boggio FL, Romagnuolo M, et al. Monkeypox: A histopathological and transmission electron microscopy study. Microorganisms 2023;11(7):1781.

12. Chalali F, Merlant M, Truong A, et al. Histological features associated with human mpox virus infection in 2022 outbreak in a nonendemic country. Clin Infect Dis 2023;76(6):1132-1135. http://doi. org/10.3390/microorganisms11071781

13. National Institute of Communicable Diseases. Multi-country mpox outbreak. May 2024. https://nicd. ac.za/wp-content/uploads/2024/05/BEYOND-OUR-BORDERS-Mpox-Outbreak-May-2024_1.pdf (accessed 30 May 2024).

14. WorldHealthOrganization.Clinicalmanagementandinfectionpreventionandcontrolformonkeypox: Interim rapid response guidance. Geneva: WHO, 10 June 2022. https://www.who.int/publications/i/item/ WHO-MPX-Clinical-and-IPC-2022.1 accessed 11 June 2024 (accessed 11 June 2024).

15. Hoy SM. Tecovirimat: First global approval. Drugs 2018;78(13):1377-1382. http://doi.org/10.1007/ s40265-018-0967-6

16. World Health Organization. Strategic framework for enhancing prevention and control of mpox 2024 - 2027. Geneva: WHO, May 2024. https://www.who.int/publications/i/item/9789240092907 (accessed 11 June 2024).

17. Centers for Disease Control. Recommendations for use of Jynneos vaccine. CDC, 13 June 2024.

https://www.cdc.gov/poxvirus/mpox/interim-considerations/overview.html#recommendations

(accessed 19 June 2024).

Downloads

Published

2024-10-03

Issue

SAMJ Vol. 114 no. 10

Section

In Practice

License

Copyright (c) 2024 E Vardas, M Naidoo, N A I Chopdat, J Weyer, A I Ranchod, L Moosa, A J Glass, L H Blumberg , J Elskie, W Garyson , T Pitjadi , Z Kalla

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Licensing Information

The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited. 

Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository. 

Publishing Rights

Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.

 

How to Cite

1.
Vardas E, Naidoo M, Chopdat NAI, Weyer J, Ranchod AI, Moosa L, et al. Severe mpox in an immunocompromised patient, South Africa 2024. S Afr Med J [Internet]. 2024 Oct. 3 [cited 2024 Dec. 9];114(10):e2407. Available from: https://samajournals.co.za/index.php/samj/article/view/2407

Similar Articles

11-20 of 109

You may also start an advanced similarity search for this article.